Literature DB >> 30726506

Evidence-based approach to active surveillance of prostate cancer.

Luke Witherspoon1, Rodney H Breau1,2, Luke T Lavallée3,4.   

Abstract

Active surveillance is a good management option for some men with non-metastatic prostate cancer. In this review, we examine the evidence for several topics related to active surveillance. We examine: (1) which patients should be eligible for active surveillance, (2) what follow-up (monitoring) protocols should be used for men on surveillance, (3) what is the role of prostate magnetic resonance imaging (MRI) for men on surveillance, and (4) what is the prognosis for men who choose surveillance compared to radical treatment. In many instances, the evidence is evolving or lacking. In these situations, we highlight the limitations of the data.

Entities:  

Keywords:  Active surveillance; Prostate cancer; Prostate cancer screening; Shared decision-making

Year:  2019        PMID: 30726506     DOI: 10.1007/s00345-019-02662-5

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  4 in total

Review 1.  Ultra-high-field MR in Prostate cancer: Feasibility and Potential.

Authors:  Carlijn J A Tenbergen; Gregory J Metzger; Tom W J Scheenen
Journal:  MAGMA       Date:  2022-05-17       Impact factor: 2.533

Review 2.  Modern imaging and image-guided treatments of the prostate gland: MR and ablation for cancer and prostatic artery embolization for benign prostatic hyperplasia.

Authors:  João Lopes Dias; Tiago Bilhim
Journal:  BJR Open       Date:  2019-08-14

3.  A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance.

Authors:  Samuel W D Merriel; Daniel Moon; Phil Dundee; Niall Corcoran; Peter Carroll; Alan Partin; Joseph A Smith; Freddie Hamdy; Caroline Moore; Piet Ost; Tony Costello
Journal:  BMC Urol       Date:  2021-02-04       Impact factor: 2.264

4.  Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up.

Authors:  Heather Johnson; Jinan Guo; Xuhui Zhang; Heqiu Zhang; Athanasios Simoulis; Alan H B Wu; Taolin Xia; Fei Li; Wanlong Tan; Allan Johnson; Nishtman Dizeyi; Per-Anders Abrahamsson; Lukas Kenner; Xiaoyan Feng; Chang Zou; Kefeng Xiao; Jenny L Persson; Lingwu Chen
Journal:  BMC Med       Date:  2020-12-01       Impact factor: 8.775

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.